Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • Histone Demethylase
    (6)
  • MAO
    (3)
  • HSV
    (1)
  • Monoamine Oxidase
    (1)
  • Others
    (6)
Filter
Search Result
Results for "

lsd1/mao-b

" in TargetMol Product Catalog
  • Inhibitors & Agonists
    15
    TargetMol | Inhibitors_Agonists
Tranylcypromine (2-PCPA) hydrochloride
Tranylcypromine (2-PCPA) HCl, SKF-385 HCl
T10251986-47-6
Tranylcypromine (2-PCPA) hydrochloride (SKF-385 HCl), a Monoamine Oxidase inhibitor, is effective in the treatment of major depression, dysthymic disorder, and atypical depression.
  • Inquiry Price
Size
QTY
GSK-LSD1 dihydrochloride
GSK-LSD1 (hydrochloride), GSK-LSD1 2HCl
T23152102933-95-7
GSK-LSD1 dihydrochloride (GSK-LSD1 2HCl) is a specificity irreversible LSD1 inhibitor (IC50: 16 nM). The selectivity of GSK-LSD1 for LSD1 is >1000 fold over other closely related FAD utilizing enzymes (i.e. MAO-A, LSD2, MAO-B).
  • Inquiry Price
Size
QTY
TargetMol | Citations Cited
OG-L002 hydrochloride
T893531357299-45-6
OG-L002 hydrochloride is an effective and highly selective inhibitor of LSD1, with an IC50 of 0.02 µM. Additionally, it serves as an efficient monoamine oxidase (MAO) inhibitor, exhibiting IC50 values of 1.38 µM for MAO-A and 0.72 µM for MAO-B. This compound also effectively suppresses the expression of the HSV1E gene.
  • Inquiry Price
10-14 weeks
Size
QTY
RN-1 dihydrochloride
T216521781835-13-9
RN-1 dihydrochloride is an effective and selective irreversible inhibitor of lysine-specific demethylase 1 (LSD1, IC50 = 70 nM).
  • Inquiry Price
Size
QTY
LSD1-IN-34
T89432
LSD1-IN-34 (Compound 7d) is an orally effective inhibitor of lysine-specific demethylase (LSD) and monoamine oxidase (MAO), exhibiting IC50 values of 4.51 nM for LSD1 and 18.46 nM for MAO A. This compound inhibits activation of neonatal rat cardiac fibroblasts (NRCF) induced by angiotensin II (Ang II) and shows no significant toxicity at 20 μM. LSD1-IN-34 also inhibits the TGFβ Smad signaling pathway, contributing to the improvement of heart failure in mice. Moreover, it demonstrates favorable pharmacokinetic properties in rats.
  • Inquiry Price
Size
QTY
lsd1-in-15
T60941
LSD1-IN-15 (compound 1b) is a potent LSD1 inhibitor that inhibits LSD1-CoREST, MAO-A, and MAO-B with IC50 values of 0.149, 0.028, and 0.327 μM, respectively. LSD1-IN-15 induces cell growth arrest in LNCaP cells of prostate cancer, with an IC50 value of 9.9 μM [1].
  • Inquiry Price
10-14 weeks
Size
QTY
lsd1/hdac6-in-2
T891342982787-50-6
LSD1 HDAC6-IN-2 (JBI-802) is an orally effective inhibitor targeting LSD1, HDAC6, and MAO-A, demonstrating IC50 values of 5 nM, 11 nM, and 5 nM, respectively. This compound effectively suppresses the growth of multiple myeloma cells, including MM.1S, MM.1R, and RPMI-8226. Additionally, LSD1 HDAC6-IN-2 is utilized for researching acute myeloid leukemia and lymphoma.
  • Inquiry Price
10-14 weeks
Size
QTY
lsd1-in-17
T61022
LSD1-IN-17 (compound 5b) is a potent inhibitor of LSD1, effectively inhibiting LSD1-CoREST, MAO-A, and MAO-B with IC50 values of 0.005, 0.028, and 0.820 μM, respectively. It induces cell growth arrest in prostate cancer LNCaP cells with an IC50 value of 17.2 μM [1].
  • Inquiry Price
10-14 weeks
Size
QTY
lsd1-in-12
T603811228143-76-7
LSD1-IN-12 (compound 2) is an effective inhibitor of LSD1, with inhibitory Ki values of 1.1 μM (LSD1), 61 μM (LSD2), 2.3 μM (MAO-A), and 3.5 μM (MAO-B) [1].
  • Inquiry Price
6-8 weeks
Size
QTY
FY-56
T61768
FY-56, a highly potent and selective inhibitor of LSD1 KDM1A with an IC50 value of 42 nM, demonstrates significant selectivity over MAO-A B. This compound effectively induces differentiation in MOLM-13 and MV4-11 cells, showing promise for acute myeloid leukemia (AML) research [1].
  • Inquiry Price
10-14 weeks
Size
QTY
Vafidemstat
ORY-2001
T172111357362-02-7
Vafidemstat (ORY-2001) is a selective, orally active lysyl-histone demethylase (LSD1) MAO-B inhibitor that crosses the blood-brain barrier for the study of neurological diseases.
  • Inquiry Price
8-10 weeks
Size
QTY
OG-L002
T60731357302-64-7
OG-L002 is an effective and selective LSD1 inhibitor (IC50: 20 nM), showing 69- and 36-fold selectivity over MAO-A and MAO-B, respectively.
  • Inquiry Price
Size
QTY
TargetMol | Inhibitor Sale
lsd1-in-16
T61021
LSD1-IN-16 (compound 4b) is a potent inhibitor of LSD1 that inhibits LSD1-CoREST, MAO-A, and MAO-B with IC50 values of 0.015, 0.024, and 0.366 μM, respectively. LSD1-IN-16 also induces cell growth arrest in prostate cancer LNCaP cells with an IC50 value of 15.2 μM [1].
  • Inquiry Price
10-14 weeks
Size
QTY
lsd1-in-26
T74858
LSD1-IN-26 (compound 12u), a potent LSD1 inhibitor, exhibits an IC50 of 25.3 nM. It also demonstrates inhibition of MAO-A (IC50 = 1234.57 nM) and MAO-B (IC50 = 3819.27 nM), significantly inducing apoptosis in MGC-803 cells. This compound is applicable in gastric cancer research [1].
  • Inquiry Price
Size
QTY
Pulrodemstat benzenesulfonate
LSD1-IN-7 benzenesulfonate, CC-90011 benzenesulfonate
T118822097523-60-7
Pulrodemstat benzenesulfonate (CC-90011 benzenesulfonate) is a potent and orally active inhibitor of lysine specific demethylase-1 (LSD1) with anticancer activity.
  • Inquiry Price
Size
QTY